GENE ONLINE|News &
Opinion
Blog

2021-05-27|

10 Precision Oncology Companies to Look Out for

by Rajaneesh K. Gopinath
Share To
According to statistics, the global precision oncology market is forecast to reach US$ 99.72 billion by 2027. Several established giants in the cancer genomics space like Illumina, Roche, Qiagen, Thermo Fisher Scientific, and Merck are positioned to soar even higher.

However, a number of promising startups that burst into the scene in the last decade and a half have attracted new capital and have extended newer technologies. Here we list 10 such precision oncology companies to look out for.

GO Prime with only $1.49 now

LATEST
From Europe to the Middle East: AMS BioteQ Expands Its Global Reach, Setting New Milestones in Medical Innovation
2024-12-02
GSK Expands Arexvy Approval to Adults Aged 50-59 at Increased Risk of Severe RSV Disease in Japan
2024-12-02
Healthcare+ Expo Taiwan 2024 To Become A Global Trade Fair With 600+ Companies Attending
2024-11-29
Cracking the Code: How Genetics Shapes Strength, Power, and Speed in Sports
2024-11-27
Shared Expertise, Shared Vision: Biotech Powerhouses Drive Innovation in This Billion-Dollar Market
2024-11-27
MIRDC Hosts Seminar Featuring Diverse Applications of Plasma Sterilization Technology
2024-11-26
How Minaris is Tackling the Scalability Challenge in Cell and Gene Therapy: A Conversation with CEO, Dr. Hiroto Bando
2024-11-26
EVENT
2024-12-05
8th Healthcare Expo Taiwan
Taipei, Taiwan
Scroll to Top